Page last updated: 2024-08-23

phosphotyrosine and atovaquone

phosphotyrosine has been researched along with atovaquone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anahtar, M; Bar-Natan, M; Blonquist, T; Bradner, JE; Frank, DA; Giaccone, ZT; Heppler, LN; Hetz, C; Ho, VT; Jones, N; Kim, H; Kroll, Y; Liu, S; Marineau, JJ; Neuberg, D; Shaw, D; Soiffer, RJ; Stone, RM; Toniolo, PA; Walker, SR; Xiang, M; Ye, DQ	1

Other Studies

1 other study(ies) available for phosphotyrosine and atovaquone

Article	Year
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent. Blood, 2016, 10-06, Volume: 128, Issue:14 Topics: Animals; Antineoplastic Agents; Apoptosis; Atovaquone; Cell Line, Tumor; Cell Membrane; Cell Survival; Cytokine Receptor gp130; Disease Models, Animal; Down-Regulation; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Mice; Phosphorylation; Phosphotyrosine; STAT3 Transcription Factor; Treatment Outcome	2016

Article

Year

Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.

Blood, 2016, 10-06, Volume: 128, Issue:14

Topics: Animals; Antineoplastic Agents; Apoptosis; Atovaquone; Cell Line, Tumor; Cell Membrane; Cell Survival; Cytokine Receptor gp130; Disease Models, Animal; Down-Regulation; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Mice; Phosphorylation; Phosphotyrosine; STAT3 Transcription Factor; Treatment Outcome

2016